Showing the single result
Genotype Press • Scientific Manuscript • Immp2l regulates mitochondrial size, NAD+ biosynthesis and autistic-like behaviour. The mitochondrial peptidase IMMP2L has been highly conserved, from E. coli to human, commensurate with its key roles in mitochondrial and cellular homeostasis, metabolism and mitochondrial dynamics. We previously reported how the loss of Immp2l activity in mice acts as an antioxidant…
PLEASE READ & AGREE TO THESE USER TERMS & CONDITIONS OF USE
These end user terms (“Terms”) apply between you (“you”) and GENOTYPE PRESS of Executive Suite G-2, P.O Box XXXX, Sutherland, NSW 2232, Australia (“GENOTYPE PRESS”) for the articles made available via the Website https://GenotypePress.com (each an “Article”).
These Terms need to be adhered to relative to the applicable law. GENOTYPE PRESS licenses Articles accessed by you, via this Website, on the terms set out below, and by so accessing you agree to be bound by these Terms. GENOTYPE PRESS remain the owners of the Article (including any intellectual property rights in the same) at all times, and no right, title or interest in any Article is transferred to you by way of the Terms; you are simply granted a limited right to use the Article as per the terms set out in these Terms. If you do not agree to these Terms, you should immediately cease accessing Articles via the Website.
GRANT AND SCOPE OF LICENSE
1. GENOTYPE PRESS licenses your use of the Articles as follows:
1. Open Access Articles: if the Article being downloaded is being made available as Open Access, it is done so under the Creative Commons license CC-BY 4.0 (a “CC Article”). You are granted a non-exclusive, non-transferable license to use the Article under the terms of the Creative Commons license CC-BY 4.0, further details of which may be found here: https://creativecommons.org/licenses/by/4.0/legalcode ; Complete terms and condition are given below for your reference purpose; Promotional Articles: if the Article being downloaded is being made available at no cost (a “Promotional Article”), you are granted a non-exclusive, non-transferable license to use the Promotional Article in accordance with these Terms below; andPayable Articles: if the Article being downloaded is being made available for purchase (a “Payable Article”), upon payment of the relevant fees in full, you are granted a non-exclusive, non-transferable license to use the Payable Article in accordance with these Terms below.
If you require a license for a Trial Article, a Promotional Article or a Payable Article that differs from the terms noted herein (such as for use within a generally available library of content or for multiple users), please contact [email protected]. (Please note that a CC Article cannot be licensed on any other terms.) If you have any queries about the scope of approved use of an Article, please contact GENOTYPE PRESS.You acknowledge that all intellectual property rights in or to the Article, throughout the world, belong to Genotype Press or its licensors, and that you have no intellectual property rights in or to the Article other than the right to use the Article in accordance with the terms set out in these Terms.
1. GENOTYPE PRESS hereby grants you, in accordance with these Terms, a non-exclusive, non-transferrable license to use the Article in the course of personal study or research (including research for commercial purposes in the context of a university or other research institution); such right to use shall not extend to any other commercial, business or resale purposes, except where otherwise specifically permitted by GENOTYPE PRESS in writing.
Any dispute or claim arising out of or in connection with these Terms will be governed by and construed in accordance with the laws of AUSTRALIA as applied in State of New South Wales of Australia. The courts of Australia will have exclusive jurisdiction over any dispute arising out of or in connection with these Terms.
If you wish to contact GENOTYPE PRESS, or if any condition in these Terms requires you to give GENOTYPE PRESS notice in writing, you can send this to GENOTYPE PRESS by email at [email protected] If GENOTYPE PRESS has to contact you, including by giving notice in writing, it will do so at the email address you provide to GENOTYPE PRESS when registering to access the Article.
By accessing the Articles, you agree to these Terms. If you do not agree to these Terms, you should immediately cease accessing Articles via the Website.
🧬GENOTYPE PRESS – 2024